Acute Kidney Injury Prevention

Risk Factors

Pre-existing kidney disease, advanced age, diabetes mellitus, volume depletion or dehydration, concurrent use of multiple potentially nephrotoxic medications, and heart failure increase vulnerability to medication-induced AKI, as recommended by the American Diabetes Association and other guideline societies 1, 2

Medications can cause AKI through hemodynamic alterations, direct tubular toxicity, intratubular obstruction, and immune-mediated injury, as reported by the National Kidney Foundation and other organizations 3, 4

Regular assessment of serum creatinine and eGFR is recommended by the American College of Cardiology to monitor kidney function, ensuring adequate hydration, avoiding high-risk medications, adjusting medication doses based on kidney function, and monitoring for drug interactions to minimize AKI risk 4
Early recognition of AKI, characterized by small increases in serum creatinine (even 0.3 mg/dL), is crucial, as indicated by the American Diabetes Association 4
Temporary withdrawal of certain medications during acute illness, especially with volume depletion, is advised by the National Kidney Foundation to prevent AKI 3
Ensuring adequate hydration, especially with diuretic therapy, and considering IV hydration if signs of AKI develop, can help mitigate the risk of AKI 5

Many medications, including those not directly nephrotoxic, require dose adjustment as kidney function changes, as recommended by the American College of Clinical Pharmacy 3, 4
High-risk medications for AKI include torsemide, NSAIDs, and metolazone, especially when combined with other nephrotoxic medications, as recommended by the American College of Nephrology 3, 6
The concurrent use of diuretics, NSAIDs, and renin-angiotensin system inhibitors significantly increases AKI risk, known as the "triple whammy" effect 6
Regular assessment of kidney function, monitoring of electrolytes, and watching for signs of volume depletion are crucial in preventing AKI, as recommended by the National Kidney Foundation 3
Dose reduction of torsemide and/or metolazone, limiting NSAID exposure, monitoring for drug interactions, and ensuring adequate hydration status can help prevent AKI, as recommended by the American College of Nephrology 6
Norco, which contains acetaminophen, can contribute to AKI at high doses, particularly with chronic use, doses approaching 3000mg/day, or dehydration, or concurrent nephrotoxic medications 3
Amiodarone can indirectly contribute to AKI through drug interactions, acting as a CYP2C9 inhibitor that can increase torsemide plasma concentrations 6